(Q33147989)

22 July 2017

title

Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole (English)

1 reference

22 July 2017

1 reference

1 reference

Christopher Banfield

1

1 reference

22 July 2017

Jerry Herron

2

1 reference

22 July 2017

Anther Keung

3

1 reference

22 July 2017

Desmond Padhi

4

1 reference

22 July 2017

Melton Affrime

5

1 reference

22 July 2017

publication date

1 January 2002

1 reference

Clinical Pharmacokinetics

22 July 2017

published in

1 reference

22 July 2017

volume

41 Suppl 1

1 reference

22 July 2017

page(s)

37-44

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200241001-00006

22 July 2017

exact match

0 references

cites work

Arrhythmogenic mechanisms of non-sedating antihistamines

1 reference

12 December 2020

Treating allergic rhinitis with second-generation antihistamines

1 reference

12 December 2020

Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine

1 reference

12 December 2020

Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines

1 reference

12 December 2020

Blockade of HERG and Kv1.5 by ketoconazole

1 reference

12 December 2020

Lack of clinically relevant interaction between desloratadine and erythromycin

1 reference

12 December 2020

Combined use of astemizole and ketoconazole resulting in torsade de pointes

1 reference

12 December 2020

Cardiovascular profile of loratadine

1 reference

12 December 2020

Torsades de Pointes after treatment with terfenadine and ketoconazole

1 reference

12 December 2020

Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

1 reference

12 December 2020

A pharmacokinetic profile of desloratadine in healthy adults, including elderly

1 reference

12 December 2020

Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity

1 reference

12 December 2020

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects

1 reference

12 December 2020

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.

1 reference

12 December 2020

10.2165/00003088-200241001-00006

Identifiers

DOI

0 references

Dimensions Publication ID

1010905235

0 references

1 reference